Publication | Open Access

An investigation of trachoma vaccine regimens by the chlamydia vaccine CTH522 administered with cationic liposomes in healthy adults (CHLM-02): a phase 1, double-blind trial

VaccinationChlamydia Vaccine Cth522Mucosal VaccinationTrachoma Vaccine RegimensVaccine DevelopmentImmunologyVaccine DesignMedicinePhase 1